Demographic trends in mortality due to ovarian cancer in the United States, 1999-2020

Table 5 Ovarian carcinoma-related age-adjusted mortality rates per 100000, stratified by age groups in females in the United States, 1999 to 2020

Year	AAMR (95%CI) in young aged (25-44 years)	AAMR (95%CI) in middle aged (45-64 years)	AAMR (95%CI) in old aged (65 to > 85 years)
1999	1.44 (1.321.55)	13.49 (13.09-13.9)	47.71 (46.76-48.65)
2000	1.43 (1.31-1.54)	13.35 (12.95-13.75)	49.27 (48.32-50.22)
2001	1.43 (1.31-1.54)	13.49 (13.09-13.88)	49.44 (48.48-50.39)
2002	1.43 (1.31-1.54)	13.55 (13.17-13.94)	49.5 (48.54-50.45)
2003	1.37 (1.26-1.49)	13.15 (12.77-13.53)	48.85 (47.91-49.79)
2004	1.43 (1.31-1.54)	12.54 (12.18-12.9)	48.85 (47.91-49.79)
2005	1.27 (1.16-1.38)	12.85 (12.5-13.21)	47.56 (46.63-48.48)
2006	1.22 (1.11-1.32)	12.44 (12.09-12.79)	47.69 (46.77-48.61)
2007	1.11 (1.01-1.21)	11.6 (11.27-11.93)	46.94 (46.04-47.85)
2008	1.26 (1.15-1.38)	11.11 (10.79-11.43)	45.35 (44.46-46.23)
2009	1.15 (1.05-1.26)	11.46 (11.14-11.78)	43.65 (42.79-44.51)
2010	1.21 (1.1-1.32)	10.99 (10.67-11.3)	44.28 (43.42-45.14)
2011	1.16 (1.06-1.27)	10.71 (10.41-11.02)	42.42 (41.58-43.25)
2012	1.11 (1-1.21)	10.63 (10.33-10.94)	41.43 (40.62-42.24)
2013	1.01 (0.91-1.11)	10.22 (9.92-10.52)	40.74 (39.95-41.54)
2014	1.16 (1.06-1.27)	9.9 (9.61-10.19)	39.44 (38.66-40.21)
2015	1.05 (0.95-1.16)	9.58 (9.29-9.86)	37.94 (37.19-38.69)
2016	1.15 (1.05-1.26)	9.66 (9.37-9.94)	37.83 (37.09-38.57)
2017	1 (0.9-1.1)	9.65 (9.37-9.94)	36.93 (36.21-37.65)
2018	1 (0.9-1.1)	9.5 (9.21-9.79)	34.9 (34.21-35.59)
2019	1 (0.9-1.1)	8.8 (8.53-9.07)	33.81 (33.14-34.48)
2020	1.05 (0.94-1.15)	9 (8.72-9.28)	33.64 (32.98-34.29)
Total	1.16 (1.14-1.19)	11.09 (11.02-11.16)	42.41 (42.23-42.59)

AAMR: Age-adjusted mortality rate; CI: Confidence interval.